CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity have?
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity has 491 citations in the OpenAlex counts ScholarIQ stores.
When was CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity published?
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity has 2019 year in the ScholarIQ index.
What is the open-access status of CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity?
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity has gold oa status in the ScholarIQ index.
What is the DOI of CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity?
The DOI for CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity is on the source record.
What is the PMID of CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity?
The PMID for CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity is on the source record.
What is the OpenAlex record for CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity?
The OpenAlex for CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity is on the source record.